title: [Does syncope change the results of programmed ventricular stimulation in patients with previous myocardial infarction?].
abstract: The induction of a ventricular tachycardia (VT) after myocardial infarction (MI) is associated with a high risk of VT and sudden death (SD) in asymptomatic patients; the purpose of the study was to know if syncope modifies the results of programmed ventricular stimulation (PVS) and the clinical consequences.
  
  
  METHODS
  PVS using two and three extra stimuli delivered in two sites of right ventricle was performed in 1057 patients without spontaneous VT or resuscitated SD at least 1 month after an acute MI; 836 patients (group I) were asymptomatic and were studied for a low ejection fraction or nonsustained VT on Holter monitoring or late potentials; 228 patients (group II) were studied for unexplained syncope. The patients were followed up to 5 years of heart transplantation.
  
  
  RESULTS
  Sustained monomorphic VT (< 280 b/min) was induced in 238 group I patients (28%) and 62 group II patients (29%); ventricular flutter (VT > 270 b/min) or ventricular fibrillation (VF) was induced in 245 group I patients (29%) and 42 group II patients (18%) (P < 0.05); PVS was negative in 353 group I patients (42%) and 124 (55%) group II patients (NS). The patients differ by their prognosis; cardiac mortality was 13% in group I patients and 34% in group II patients with inducible VT < 280 b/min (P < 0.01), 4% in group I patients and 13% in group II patients with inducible VF (P < 0.05), 5% in group I patients and 7% in group II patients with negative study (NS). In conclusion, syncope did not change the results of programmed ventricular stimulation after myocardial infarction. However, syncope increased significantly cardiac mortality of patients with inducible ventricular tachycardia, flutter or fibrillation.
authors.affiliation: Service de cardiologie, CHU de Brabois, rue du Morvan, 54500 Vandoeuvre-les-Nancy, France. b.brembilla-perrot@chu-nancy.fr
authors.forename: B
authors.initials: B
authors.lastname: Brembilla-Perrot
authors.forename: C
authors.initials: C
authors.lastname: Suty-Selton
authors.forename: D
authors.initials: D
authors.lastname: Beurrier
authors.forename: P
authors.initials: P
authors.lastname: Houriez
authors.forename: A
authors.initials: A
authors.lastname: Terrier de la Chaise
authors.forename: P
authors.initials: P
authors.lastname: Louis
authors.forename: O
authors.initials: O
authors.lastname: Claudon
authors.forename: M
authors.initials: M
authors.lastname: Andronache
authors.forename: N
authors.initials: N
authors.lastname: Sadoul
authors.forename: Y
authors.initials: Y
authors.lastname: Juillière
authors.forename: M
authors.initials: M
authors.lastname: Nippert
authors.forename: B
authors.initials: B
authors.lastname: Popovic
authors.forename: H
authors.initials: H
authors.lastname: Blangy
mesh_terms: D000328:Adult; D000368:Aged; D002304:Cardiac Pacing, Artificial; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications*; D017063:Outcome Assessment, Health Care; D011379:Prognosis; D013575:Syncope / Q000628:therapy*; D017180:Tachycardia, Ventricular / Q000209:etiology / Q000401:mortality / Q000628:therapy*